Search - tctmd.com

Displaying 1 - 20 of 25

Sort: Relevancy | Date

News Conference News TVT 2023

‘Excellent’ Outcomes With Mitral ViV Procedures, Even in Lower-Risk Patients

Michael O'Riordan

June 09, 2023

Presentation TVT 2023

The “Breakthrough Device” Designation: Agony, Ecstasy, and Clinical Trial Landmines

Presenter: Jaime Raben

June 09, 2023

Presentation TVT 2023

Early Feasibility Studies (EFS) “2.0”: The Next Decade

Presenter: Andrew Farb

June 09, 2023

Presentation TVT 2023

Transcatheter and Digital Heart Failure Technologies: Deconvoluting the Myriad Strategies and Therapies for a Multitude of HF-related Syndromes

Presenter: Daniel Burkhoff

June 09, 2023

Presentation TVT 2023

TMVR Reaching Adolescence: The Delicate Alignment of Anatomic Challenges, Clinical Need, and Device Performance

Presenter: Juan Granada

June 09, 2023

Presentation TVT 2023

Highlighting the Importance and Pitfalls in Interpreting Patient Reported Outcomes

Presenter: David Cohen

June 08, 2023

Presentation TVT 2023

Lessons Learned from the TRILUMINATE Trial: Balancing the Safety and Efficacy of Transcatheter Tricuspid Valve Repair

Presenter: Paul Sorajja

June 08, 2023

Presentation TVT 2023

Setting the LAAO Stage: Achievements, Speedbumps, and Remaining Controversies

Presenter: Devi Nair

June 08, 2023

Presentation TVT 2023

Highlighting the TAVR Access to Care Dilemma

Presenter: Larry Wood

June 08, 2023

Presentation TVT 2023

Lessons Learned from the PROTECTED TAVR Trial: Mapping the Future of Cerebral Embolic Protection

Presenter: Samir Kapadia

June 08, 2023

Presentation TVT 2022

Keynote Lecture: Unique Insights From the University of Leiden Longitudinal Valvular Heart Disease Clinical Research Experience

Presenter: Jeroen Bax

June 08, 2022

Presentation TVT 2022

Keynote Lecture: Perspectives on Healthcare Disparities in Structural Heart Disease

Presenter: Ashwin Nathan

June 08, 2022

Presentation TVT 2022

From National Registries to Pragmatic Clinical Trials, From Patient-Reported Outcomes to Shared Decision-making: Not One Size Fits All!

Presenter: Sreekanth Vemulapalli

June 08, 2022

Presentation TVT 2022

Keynote Lecture: Unlocking the Mysteries of Tricuspid Valve Disease: Controversies and Technologies1

Presenter: Azeem Latib

June 08, 2022

Presentation TVT 2019

Neochord Transapical: Technology, FDA Pivotal Trial Updates (RECHORD), Progress With Transseptal Version

Presenter: Gilbert Tang

June 14, 2019

Presentation TVT 2019

Large-Hole Transfemoral Closure I: The FDA-Approved MANTA Device

Presenter: Nicolas Van Mieghem

June 13, 2019

News Conference News TVT 2017

Lagging Behind: Guidelines Can’t Keep Up With Growing TAVR Evidence Base

Michael O'Riordan

June 17, 2017

News Conference News TVT 2017

Reacting to REPRISE III: Enthusiasm, Explanations, and Caveats for the Lotus Pivotal TAVR Trial

Shelley Wood

June 16, 2017

News Conference News TVT 2017

Embolic Protection During TAVR Reduces Stroke Risk, Single-Center Study Shows

Michael O'Riordan

June 15, 2017

News Conference News TVT 2017

Mitral Valve Repair Technologies Inch Forward, but Question of Combination Therapy Looms

Shelley Wood

June 15, 2017

Advertisement

‘Excellent’ Outcomes With Mitral ViV Procedures, Even in Lower-Risk Patients

The “Breakthrough Device” Designation: Agony, Ecstasy, and Clinical Trial Landmines

Early Feasibility Studies (EFS) “2.0”: The Next Decade

Transcatheter and Digital Heart Failure Technologies: Deconvoluting the Myriad Strategies and Therapies for a Multitude of HF-related Syndromes

TMVR Reaching Adolescence: The Delicate Alignment of Anatomic Challenges, Clinical Need, and Device Performance

Highlighting the Importance and Pitfalls in Interpreting Patient Reported Outcomes

Lessons Learned from the TRILUMINATE Trial: Balancing the Safety and Efficacy of Transcatheter Tricuspid Valve Repair

Setting the LAAO Stage: Achievements, Speedbumps, and Remaining Controversies

Highlighting the TAVR Access to Care Dilemma

Lessons Learned from the PROTECTED TAVR Trial: Mapping the Future of Cerebral Embolic Protection

Keynote Lecture: Unique Insights From the University of Leiden Longitudinal Valvular Heart Disease Clinical Research Experience

Keynote Lecture: Perspectives on Healthcare Disparities in Structural Heart Disease

From National Registries to Pragmatic Clinical Trials, From Patient-Reported Outcomes to Shared Decision-making: Not One Size Fits All!

Keynote Lecture: Unlocking the Mysteries of Tricuspid Valve Disease: Controversies and Technologies1

Neochord Transapical: Technology, FDA Pivotal Trial Updates (RECHORD), Progress With Transseptal Version

Large-Hole Transfemoral Closure I: The FDA-Approved MANTA Device

Lagging Behind: Guidelines Can’t Keep Up With Growing TAVR Evidence Base

Reacting to REPRISE III: Enthusiasm, Explanations, and Caveats for the Lotus Pivotal TAVR Trial

Embolic Protection During TAVR Reduces Stroke Risk, Single-Center Study Shows

Mitral Valve Repair Technologies Inch Forward, but Question of Combination Therapy Looms

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content